A cerebral aneurysm is a serious and potentially fatal medical condition that occurs when a part of a blood vessel in the brain weakens and bulges. It is also referred to as an intracranial aneurysm. Cerebral aneurysms can occur in any area of the brain where blood vessels are present. The exact cause of a cerebral aneurysm is unknown, but research suggests that it may be the result of certain medical conditions such as hypertension (high blood pressure), or genetic factors that weaken the walls of arteries. These weakened sections of artery may become dilated or filled with blood, forming a sac-like bulge, known as an aneurysm. In some cases, a cerebral aneurysm may rupture, which can cause bleeding inside the brain. This is known as an intracerebral hemorrhage and can cause a wide range of neurological symptoms and complications such as headaches, seizures, and coma. The only way to definitively diagnose a cerebral aneurysm is with an angiogram. During an angiogram, dye is injected into the bloodstream and used to create an X-ray image of the brain. This allows the doctor to identify the exact location and size of the aneurysm. Certain risk factors, including advanced age, female gender, smoking, and a family history of cerebral aneurysm, can increase the likelihood of developing this condition. If an aneurysm is identified, treatment typically involves the placement of a coil or stent, or in some cases, a surgical procedure. These treatments are aimed at preventing the aneurysm from growing larger or rupturing. In some cases, a brain aneurysm may not present symptoms or require treatment. In conclusion, a cerebral aneurysm is a potentially serious medical condition that can cause a range of neurological symptoms and complications. It is important to recognize the signs and symptoms of a cerebral aneurysm and consult with your doctor to determine if an angiogram is necessary.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States